Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

3

Revenue 2017

MabThera/Rituxan

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. MabThera/Rituxan was produced by Roche.

Sandoz says Humira biosimilar clears clinical hurdle

Sandoz says Humira biosimilar clears clinical hurdle review of the company's biosimilar version Roche's immunotherapy drug Rituxan (rituximab), another blockbuster with sales of $4bn in the first half of the year.

Roche faces prospect of second Rituxan biosimilar in US

Roche faces prospect of second Rituxan biosimilar in US The US Food and Drug Administration (FDA) has started its review of a second biosimilar rival to Roche's blockbuster immunotherapy drug Rituxan, with Novartis' Sandoz unit seeking to dent its ... Rituxan is used to treat blood cancers including

Kite files first CAR-T candidate in Europe

Kite files first CAR-T candidate in Europe cytokine-release syndrome (CRS), which can be fatal if not managed but has also been seen with antibody therapies such as Roche's MabThera (rituximab).

Ocrevus off to a flying start as Roche raises 2017 forecasts

Ocrevus off to a flying start as Roche raises 2017 forecasts Roche's mainstay biologic cancer therapies also held up well in the face of biosimilar competition in some markets, with Herceptin (trastuzumab) and MabThera/Rituxan (rituximab) both gaining 3% to

NICE backs Cancer Drugs Fund support for Roche's Gazyvaro

NICE backs Cancer Drugs Fund support for Roche's Gazyvaro on Roche's MabThera (rituximab) - and as monotherapy for maintenance thereafter - via the CDF. ... Like MabThera, Gazyvaro targets the CD20 receptor but has been designed with sugar molecule side chains that improve its therapeutic and safety profile.

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics